ABBOTT LABORATORIES Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31)
ABBOTT LABORATORIES (ABT) reported Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) of 3 Y for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-07.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition · last filed 2012-11-07
- ABBOTT LABORATORIES employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition (deprecated 2012-01-31) for the quarter ending 2012-03-31 was 3.00 Y.
- ABBOTT LABORATORIES employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition (deprecated 2012-01-31) for fiscal 2011 was 3.00 Y.
| Period end | Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 3 month | Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 6 month | Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 9 month | Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-09-30 | 3.00 Y 10-Q · filed 2012-11-07 | |||
| 2012-06-30 | 3.00 Y 10-Q · filed 2012-08-07 | |||
| 2012-03-31 | 3.00 Y 10-Q · filed 2012-05-08 | |||
| 2011-12-31 | 3.00 Y 10-K · filed 2012-02-21 | |||
| 2011-09-30 | 3.00 Y 10-Q · filed 2011-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |